MGX
Metagenomi, Inc. Common Stock
NASDAQ · USHealthcareBiotechnology
$1.22-1.61%
Price as of Jul 20, 2026
MGX valuation
Metagenomi, Inc. Common Stock valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.59x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.33x
- Price / sales
- 2.06x
- Price / cash flow
- -0.53x
Enterprise value
- Enterprise value
- -$55.0M
- EV / sales
- -2.47x
- EV / EBITDA
- 0.68x
- EV / EBIT
- 0.59x
- Market cap
- $45.9M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.